Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) Assets Average (2022 - 2025)

Historic Assets Average for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to $448.9 million.

  • Abivax's Assets Average changed N/A to $448.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $448.9 million, marking a year-over-year change of. This contributed to the annual value of $286.5 million for FY2024, which is 3222.95% up from last year.
  • As of Q3 2025, Abivax's Assets Average stood at $448.9 million.
  • Over the past 5 years, Abivax's Assets Average peaked at $448.9 million during Q3 2025, and registered a low of $101.0 million during Q4 2022.
  • For the 3-year period, Abivax's Assets Average averaged around $223.5 million, with its median value being $197.5 million (2025).
  • Examining YoY changes over the last 5 years, Abivax's Assets Average showed a top increase of 11233.17% in 2023 and a maximum decrease of 11233.17% in 2023.
  • Quarter analysis of 3 years shows Abivax's Assets Average stood at $101.0 million in 2022, then soared by 112.33% to $214.5 million in 2023, then surged by 109.27% to $448.9 million in 2025.
  • Its Assets Average stands at $448.9 million for Q3 2025, versus $155.5 million for Q2 2025 and $197.5 million for Q1 2025.